Location History:
- Levittown, PA (US) (1986)
- Plainsboro, NJ (US) (1991)
Company Filing History:
Years Active: 1986-1991
Title: The Innovations of Steven M Peseckis: Pioneering Antithrombotic and Cardiotonic Therapies
Introduction: Steven M Peseckis is an influential inventor based in Plainsboro, NJ, known for his contributions to the fields of pharmaceuticals and therapeutics. With two notable patents to his name, Peseckis has played a key role in developing compounds that significantly enhance medical treatment options for conditions related to cardiac health and thromboembolic disorders.
Latest Patents: Steven M Peseckis's latest patents include innovative compounds designed as antithrombotic agents. The first patent details 5-substituted-6-aminopyrimidine derivatives, specifically a compound formula wherein R.sup.1 is --OH or --NH.sub.2, R.sup.2 and R.sup.3 are halogens or --CN, and n is an integer ranging from 1 to 3. These compounds, or their pharmaceutically acceptable salts, are useful for preventing thrombus formation. Another significant invention by Peseckis focuses on amino-pyrimidine derivatives that have therapeutic applications for increasing cardiac contractility in mammals. This patent outlines both the composition and methods for utiliser of these derivatives, highlighting their potential to improve cardiac function in patients.
Career Highlights: Peseckis is affiliated with American Home Products Corporation, where his expertise in medicinal chemistry and pharmaceutical development has been pivotal. His innovative research has not only yielded patents but also contributed to the advancement of therapeutic strategies in cardiology and hematology.
Collaborations: Throughout his career, Steven M Peseckis has collaborated with notable colleagues such as Jehan F Bagli and Richard J Heaslip. These partnerships have fostered an environment of innovation and creativity, enabling the development of groundbreaking therapies that can benefit a wide range of patients.
Conclusion: Steven M Peseckis stands out as a dedicated inventor whose work has the potential to transform treatment protocols in cardiac and thromboembolic care. His patents serve as a testament to his commitment to enhancing patient health and expanding the horizons of pharmaceutical science.